Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 03 2021
Historique:
received: 18 01 2021
accepted: 08 03 2021
entrez: 26 3 2021
pubmed: 27 3 2021
medline: 21 10 2021
Statut: epublish

Résumé

Insulin balls, localized insulin amyloids formed at subcutaneous insulin-injection sites in patients with diabetes, cause poor glycemic control owing to impairments in insulin absorption. Our previous study has shown that some insulin balls are cytotoxic, but others are not, implying amyloid polymorphism. Interestingly, the patient with toxic insulin balls had been treated with antibiotic minocycline, suggesting a possible relationship between toxicity of insulin balls and minocycline. However, the direct effect of minocycline on the structure and cytotoxicity of the insulin amyloid is still unclear. Herein, we demonstrated that that minocycline at physiological concentrations induced degradation of insulin amyloids formed from human insulin and insulin drug preparations used for diabetes patients. Interestingly, the process involved the initial appearance of the toxic species, which subsequently changed into less-toxic species. It is also shown that the structure of the toxic species was similar to that of sonicated fragments of human insulin amyloids. Our study shed new light on the clarification of the revelation of insulin balls and the development of the insulin analogs for diabetes therapy.

Identifiants

pubmed: 33767265
doi: 10.1038/s41598-021-86001-y
pii: 10.1038/s41598-021-86001-y
pmc: PMC7994847
doi:

Substances chimiques

Amyloid 0
Anti-Bacterial Agents 0
Insulin 0
Minocycline FYY3R43WGO

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6857

Références

Nat Rev Drug Discov. 2016 Jun;15(6):425-39
pubmed: 26988411
Biochim Biophys Acta. 2010 Jul;1804(7):1405-12
pubmed: 20399286
BMC Endocr Disord. 2019 Jun 13;19(1):61
pubmed: 31196059
Int J Pharm. 2018 Aug 25;547(1-2):450-468
pubmed: 29890260
Angew Chem Int Ed Engl. 2008;47(37):7114-8
pubmed: 18688904
J Biol Chem. 2011 Jan 21;286(3):2121-31
pubmed: 21068391
Am J Med. 2014 May;127(5):450-4
pubmed: 24462809
Int J Pharm. 2018 Aug 25;547(1-2):621-629
pubmed: 29928940
FEBS J. 2010 Mar;277(6):1348-58
pubmed: 20148964
Philos Trans R Soc Lond B Biol Sci. 1988 Jul 6;319(1195):369-456
pubmed: 2905485
Org Biomol Chem. 2011 Dec 21;9(24):8356-70
pubmed: 22051883
J Biol Chem. 2005 Dec 30;280(52):42669-75
pubmed: 16246845
ACS Chem Biol. 2010 Aug 20;5(8):735-40
pubmed: 20550130
Diabetes. 1972;21(2 Suppl):492-505
pubmed: 5054329
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):18990-5
pubmed: 19864624
Methods Mol Biol. 2018;1779:485-496
pubmed: 29886552
Amyloid. 2016 Dec;23(4):209-213
pubmed: 27884064
PLoS One. 2011;6(11):e27906
pubmed: 22132167
Biopolymers. 1991 Jan;31(1):119-28
pubmed: 2025683
EMBO J. 2001 Apr 17;20(8):1829-39
pubmed: 11296217
Int J Mol Sci. 2012;13(2):1461-80
pubmed: 22408402
J Vis Exp. 2017 Oct 20;(128):
pubmed: 29155738
ACS Chem Biol. 2009 Aug 21;4(8):673-84
pubmed: 19624097
Lancet. 2009 Jan 10;373(9658):184
pubmed: 19135614
Nat Rev Endocrinol. 2017 Jul;13(7):385-399
pubmed: 28429780
Biochemistry. 2012 Mar 20;51(11):2172-80
pubmed: 22352808
Biophys J. 2009 Apr 22;96(8):3331-40
pubmed: 19383476
Life Sci. 2019 Feb 15;219:90-99
pubmed: 30639280
J Med Chem. 2019 Feb 28;62(4):2038-2048
pubmed: 30707834
Chemphyschem. 2018 Nov 19;19(22):3001-3009
pubmed: 30183138
Structure. 1996 Aug 15;4(8):989-98
pubmed: 8805583
Science. 2003 Apr 18;300(5618):486-9
pubmed: 12702875
AAPS J. 2017 Mar;19(2):397-408
pubmed: 28000098
Biochemistry. 2006 Aug 1;45(30):9342-53
pubmed: 16866381
Pathol Res Pract. 2017 Oct;213(10):1237-1241
pubmed: 28935176
Biochim Biophys Acta. 2015 Mar;1854(3):209-17
pubmed: 25528988
Diabetologia. 1988 Mar;31(3):158-61
pubmed: 3286343
Prion. 2010 Jan-Mar;4(1):20-5
pubmed: 20305394
Biotechnol Bioeng. 2011 Oct;108(10):2359-70
pubmed: 21520027
J Diabetes Investig. 2020 Jul;11(4):1002-1005
pubmed: 31867887
Front Neurosci. 2017 Feb 14;11:64
pubmed: 28261044
Sci Rep. 2016 Aug 25;6:32022
pubmed: 27558445
Protein Sci. 2018 Nov;27(11):1901-1909
pubmed: 30125425
Amyloid. 2016 Jun;23(2):98-108
pubmed: 26987044
Diabetes Care. 2021 Jan;44(Suppl 1):S111-S124
pubmed: 33298420

Auteurs

Wakako Mori (W)

Department of Chemistry and Biology, Graduate School of Science and Engineering, Ehime University, Ehime, 790-8577, Japan.

Keisuke Yuzu (K)

Department of Chemistry and Biology, Graduate School of Science and Engineering, Ehime University, Ehime, 790-8577, Japan.

Nadine Lobsiger (N)

Department of Chemistry and Biology, Graduate School of Science and Engineering, Ehime University, Ehime, 790-8577, Japan.
Institute for Chemical and Bioengineering, ETH Zürich, 8093, Zürich, Switzerland.

Hideo Nishioka (H)

Application Management Department, JEOL Ltd, Tokyo, 196-8558, Japan.

Hisako Sato (H)

Department of Chemistry and Biology, Graduate School of Science and Engineering, Ehime University, Ehime, 790-8577, Japan.

Terumasa Nagase (T)

Department of Metabolism and Endocrinology, Tokyo Medical University Ibaraki Medical Center, Ibaraki, 3000395, Japan.

Keiichi Iwaya (K)

Department of Pathology, SASAKI Institute, Kyoundo Hospital, Tokyo, 101-0062, Japan.

Mikael Lindgren (M)

Department of Physics, Faculty of Natural Sciences, Norwegian University of Science and Technology, 7491, Trondheim, Norway.

Tamotsu Zako (T)

Department of Chemistry and Biology, Graduate School of Science and Engineering, Ehime University, Ehime, 790-8577, Japan. zako.tamotsu.us@ehime-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH